药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zopiclone
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Bismuth subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Lafutidine
Lafutidine can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Magaldrate
Magaldrate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Metiamide
Metiamide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Magnesium oxide
Magnesium oxide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zopiclone
Tibolone
Tibolone may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
Sugammadex
The risk or severity of bleeding and hemorrhage can be increased when Dabigatran etexilate is combined with Sugammadex.
Zopiclone
Obinutuzumab
The risk or severity of bleeding and hemorrhage can be increased when Dabigatran etexilate is combined with Obinutuzumab.
Zopiclone
Ibrutinib
The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Dabigatran etexilate.
Zopiclone
Hyodeoxycholic Acid
The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Hyodeoxycholic Acid.
Zopiclone
Dehydrocholic acid
The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Dehydrocholic acid.
Zopiclone
Bamet-UD2
The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Bamet-UD2.